Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis
Hossein Azadeh, Reza Alizadeh‐Navaei, Alireza Rezaiemanesh, Misagh Rajabinejad
Topics & Concepts
MedicineSecukinumabInternal medicinePlaceboAnkylosing spondylitisAdverse effectRandomized controlled trialIxekizumabImmune systemClinical trialImmunologyDiseasePathologyPsoriatic arthritisAlternative medicineSpondyloarthritis Studies and TreatmentsPsoriasis: Treatment and PathogenesisRheumatoid Arthritis Research and Therapies